Hong Kong Construction Stock News

HashKey Holdings closed at HK$2.635 after a choppy few months that left the stock down over the past quarter but still sharply higher over 30 days. The market is trading short term noise. The real story in these half year numbers is the growing loss profile sitting under a high revenue growth narrative. H1 2026 revenue came in at HK$342.524 million while the company reported a net loss of HK$691.102 million and a basic loss per share of HK$0.249857. With the stock valued at roughly 9.3x...

China Longyuan Power Group stock has been grinding lower for months, yet the latest Q2 numbers hand investors a fresh headache. The headline is margin pressure. Trailing net profit margin over the past year sits at 12.5%, compared with 18.5% a year earlier, while quarterly basic earnings per share in Q2 came in at ¥0.092 on revenue of ¥6.8b. That squeeze matters more than any one day’s price move, because it goes straight to the question of how much earnings power this renewables utility can...

Trigiant Group stock went into this earnings print trading on a low P/E of 9.5x against much richer industry multiples, with the market already aware of its sharp share price swings in recent months. Today's H1 2026 numbers put that discount under a brighter light. The wired and cable maker reported net income of ¥208.449 million on revenue of ¥1,750.498 million, following a return to profitability over the last twelve months. The gap between a volatile share price and a business that is now...

iDreamSky Technology Holdings stock closed at HK$0.435 today, capping a 61.1% rise over the past month. The price move suggests this gaming stock has been in favour. The new earnings print highlights why investors are now debating how much is already priced in. The headline result is straightforward: iDreamSky remained profitable for H1 2026 with basic earnings per share of ¥0.01 and net income from ongoing operations of ¥21.83m. This profit figure matters when set against a trailing P/E of...

Angang Steel stock closed at HK$1.22 after the market had a day to absorb its Q2 numbers. The price sits on top of a flat 30 day return and a small gain over the past week, which suggests investors are still undecided on what comes next. The headline is not about a sudden turnaround. Angang Steel remains loss making, with Q2 net income excluding extra items showing a loss of CNY 590 million and trailing twelve month losses of CNY 5.0b. The real question for you now is how long those losses...

Xizang Zhihui Mining stock closed at HK$18.90 after a choppy week that left shares down about 12% over seven days, but still meaningfully higher over the past three months. The short term has been noisy. The headline is clear: H1 2026 showed heavy lifting in the profit engine, with net margin sitting at 30.2% on trailing numbers and earnings over the past year more than doubling. That profit story now runs into a rich 35.6x P/E and a discounted cash flow estimate above the current price. The...

ManpowerGroup Greater China stock has barely moved over the past week, yet the latest earnings land with a valuation story that is hard to ignore. The company is generating earnings that translate into a trailing P/E of 5.5x while peers in Asian professional services trade on much richer multiples. At the same time, the shares change hands at a tiny fraction of a discounted cash flow fair value estimate. Short term price action looks sleepy, but the earnings print refreshes a longer term...

Jinhai Medical Technology stock has been on a tear, with the share price up sharply over the past month and quarter. Yet the latest earnings remind you that this is still a loss-making business. The headline from H1 2026 is not the top line. Instead, it is the squeeze on profitability, with Jinhai reporting a net loss of S$4.362 million and basic earnings per share still in the red. Short term traders have been rewarded by price momentum. Longer term investors now need to weigh those gains...

China Renaissance Holdings walked into this earnings day with the stock quietly grinding higher over the past month and a P/E that sat between its capital markets peers and the wider Hong Kong industry. The headline this time is simple: profit is back on the table but thinner than many investors might like to see. First half 2026 revenue reached C¥487.1m and basic earnings per share came in at C¥0.08, supported by a trailing twelve month profit of C¥76.9m. The market now needs to decide...

Digital Domain Holdings stock came into these results under quiet pressure. The share price has slipped around 4% over the past week and about 6% over the past month, even before the market had a full day to digest the new numbers. The headline is not revenue growth. The story is an entertainment technology company that remains loss making and faces a clear balance sheet strain, with less than one year of cash runway and a valuation that still prices the stock above the broader Hong Kong...

Huaibei GreenGold Industry Investment closed at HK$13.31 after the market had time to digest its latest half year numbers, and the stock price move sat against a backdrop of rising losses and a demanding valuation. The market has treated this as a high growth story in basic materials, yet the headline from this H1 2026 release is a deeper loss on modest revenue and a trailing twelve month price to sales multiple near 21x. For you as a shareholder, the tension is clear. Losses are widening...

Weichai Power stock has drifted in recent months, with the Hong Kong listing down about 21% over the past quarter, yet the latest earnings tell a sharper story. Q2 basic earnings per share came in at ¥0.53, on revenue of about ¥60.6b, as profit growth outpaced the modest revenue line. That combination feeds straight into a trailing P/E of 18.7x, a clear premium to Hong Kong machinery peers. The key issue now is whether that profit momentum justifies the higher multiple over the next few...

China Everbright stock barely flinched into these results, with the share price up only 0.97% over the past month even as the company reported another heavy half year loss. The headline is simple: H1 2026 swung to a loss of HK$1.97b and basic earnings per share fell to a loss of HK$1.22. Against that, investors are still paying a rich price for each dollar of sales. The trailing price to sales multiple sits at 13.1x, far above both the Hong Kong capital markets average and the peer group. The...

Shandong Boan Biotechnology stock has been under pressure, with the share price down about 35% over the past three months and closing at HK$3.73 on 28 August. The fresh H1 2026 numbers explain why short term traders are uneasy. Revenue came in at C¥233.0 million while the company swung to a basic loss per share of C¥0.13. The real story for long term investors now shifts to the balance between that loss, a still developing product pipeline, and a relatively low 3.2x P/S multiple compared with...

Shougang Fushan Resources Group stock has been grinding higher in recent weeks, yet today’s move came down to one blunt question. Does a coal producer with a trailing P/E of 18.3x and a 4.09% yield that strains free cash flow really deserve this much optimism after its latest half year? The headline is not the revenue line. It is the squeeze on profitability. Net profit margin over the last year sat at 13.2%, well below the prior 22.9%. That is the pressure point the market is wrestling with,...

JW (Cayman) Therapeutics came into this earnings print as a cheap revenue story, trading on a P/S ratio below both Hong Kong biotech peers and the wider sector, with the stock up 42.4% over the past month. The headline this half is not the share price. It is the sharp compression in reported losses. H1 2026 revenue reached ¥111.4 million, while the company cut its net loss to ¥50.4 million and basic earnings per share loss to ¥0.12. For a still unprofitable cell therapy developer, that scale...

Guangdong Tianyu Semiconductor stock closed at HK$38.30, roughly flat over the past week after a weak three month stretch. The market reaction looks calm, yet the headline from H1 2026 is anything but. Revenue reached ¥347.9m, while the company swung from a small H1 2025 profit to a loss of ¥119.8m and basic earnings per share of ¥0.30 in the red. The short term story is a profit squeeze. The longer term story is whether forecast revenue growth and a potential path back to profitability can...

Tian Tu Capital stock has been drifting lower in recent weeks, yet the latest quarter delivered a very different message. Q2 2026 showed Total Revenue of C¥267.3 million and Net Income of C¥147.3 million, which sits against a trailing P/E of 6.1x that still prices in plenty of scepticism. The headline here is simple: a volatile Hong Kong capital markets stock that recently returned to profitability has just reported another profitable quarter. The full story now turns on how durable this...

Shanghai Chicmax Cosmetic closed at HK$22.52 after a tough run, with the stock down about 38% over the past three months. Yet the latest half year earnings tell a different story from the share price slide. Revenue for the first half of 2026 came in at CNY 3,756.5m, while basic earnings per share were CNY 0.27, which puts fresh focus on profitability rather than top line scale. The real headline is margin pressure. Trailing net profit margin is now 7.8% compared with 12.2% a year earlier...

Shenzhen Investment just closed at HK$0.70, with the stock drifting over the past week, while the new half year numbers point to a deeper issue that goes beyond a soft share price. The key story is not revenue; it is the scale and persistence of losses. Basic earnings per share for the first half came in negative again, and net income stayed firmly in the red. For a highly leveraged property developer, that loss trend and weak interest coverage are what really challenge the bullish case, no...

China Life Insurance stock went into this earnings print already grinding higher, with steady gains over the past week and month. Yet the real story sat in the profit engine. Net income for Q2 landed at ¥114,984m on revenue of ¥189,561m, reinforcing a wide earnings cushion for a life insurer that investors often value on consistency and capital strength. The headline for today is simple. China Life Insurance is generating substantial profits while trading on a P/E of 2.9x that is well below...

Transtech Optelecom Science Holdings has been trading like a turnaround story, with the stock up about 73% over the past three months and roughly 59% over the past month. However, the latest move into earnings was slightly softer, with a 7 day decline. The new H1 2026 numbers show why the story is so polarising. Revenue sits at HK$143.4m and basic earnings per share hit HK$0.142, but the trailing 12 month figures still point to a loss, and a high price to sales multiple of 15.8x keeps...

Kindstar Globalgene Technology stock closed at HK$0.97 after a mixed stretch for shareholders, with a small gain over the past month and a weaker 90 day run. The market is reacting to one core message in these H1 2026 results: losses continue, yet the earnings drag is easing while revenue holds close to recent levels. The real story now sits beyond today’s tick-by-tick action. Trailing 12 month revenue is C¥950.3m and the loss from continuing operations is C¥40.6m, which is smaller than in...

Wasion Holdings closed at HK$15.41 after a rough three months where the stock gave up almost 29%. That kind of slide hints at investors bracing for an earnings stumble. Instead, H1 2026 landed with a clean headline. Revenue came in at ¥5,389.4m and basic earnings per share were ¥0.444, broadly in line with the recent run rate. The real tension today is psychological. The market has been pricing in trouble, while trailing twelve month earnings growth and a 13x P/E against richer peers point to...